Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Letter From The Editor Previous | All Articles This Week | Next
This article originally posted 22 June, 2011 and appeared in  MedicationGLP-1 Series Issue 3GLP-1 Agonist

GLP-1 Issue #3 Editor's Note

This week we have the results from our GLP-1 Survey. Thanks to the great number of you who participated, and congratulations to Dr. Donald W., of Southern Pines, North Carolina, the winner of our Kindle/Nook giveaway.

As we put together the original survey, our first thoughts were to find out what you wanted to know about GLP-1 analogs, and what your impressions of this class of drugs are. Click here to find out what your colleagues had to say.

Many of you have your own opinions on GLP-1 analogs. We thought you might like to hear how Dr. Aaron Vinik, Director, EVMS Strelitz Diabetes Research Center, uses GLP-1 analogs in his practice, and why and how he selects the patients for GLP-1 analog therapy.

And after you have read the first two features, be sure to review the case of A Caucasian Man with Newly Diagnosed Type 2 Diabetes and Renal Insufficiency, Part 1.

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 22 June, 2011 and appeared in  MedicationGLP-1 Series Issue 3GLP-1 Agonist

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control